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Background. Isolated tricuspid valve endocarditis in the absence of risk factors in the community setting is very rare and can be
easilymissedinpatientswithhithertonormalvalves.CasePresentation.Wepresentacaseofa49yearoldgentlemanwhopresented
with generalized body aches, fever, and jaundice and was initial diagnosed as hepatitis. He subsequently developed recurrent
episodes of panic attacks and shortness of breath and later multiple skin abscesses. Further investigations excluded pulmonary
embolismbutrevealedmultipleabscessesinthebodyincludingthelungs.BloodculturesandculturefromabscessesgrewS.aureus.
An initial transthoracic echocardiogram was normal. A transesophageal echocardiogram subsequently conﬁrmed endocarditis on
a normal natural tricuspid valve and multiple lung abscesses. He was successfully treated with appropriate antibiotics. Conclusion.
We discuss the pathogenesis of this patient’s presentation highlight the need for assessment and proper evaluation of patients with
unexplained bacteremia.
1.Introduction
Staphylococcus aureus is an important cause of community-
acquired bacteremia and is associated with substantial mor-
bidity and mortality [1–3]. A recent population-based sur-
veillance study reported Staphylococcus aureus as being the
most common cause of nosocomial bacteremia and the
second most common cause of community-acquired bacter-
emia [4]. An earlier retrospective survey from the same pop-
ulation (Olmsted County, Minnesota) which is said to be
a relatively isolated community over a period of 30 years
(1970–2000) by Tleyjeh et al. [5] also revealed that S. aureus
(26%)wassecondonlytoviridiansgroupstreptococci(44%)
as the principal causative agent of infective endocarditis.
However, Fowler and colleagues [6]u n d e r t o o kap r o s p e c t i v e
analysis of S. aureus endocarditis cases seen at 39 medical
centers in 16 countries from June 2000 through December
2003 and reported that Staphylococcus aureus was the patho-
gen identiﬁed most frequently.
Staphylococcus aureus owes its virulence to the presence
of toxins (alpha-toxin, beta-toxin, gamma-toxin, delta-toxin,
exfoliatin, enterotoxins, Panton-Valentine leukocidin (PVL),
and toxic shock syndrome toxin-1 (TSST-1)) [7]. Up to 80%
of people are colonized with S. aureus; most only intermit-
tently but up to 20–30% are persistently colonized. Colo-
nization rates in health care workers, persons with diabetes,
and patients on dialysis are more than in the general popu-
lation. The anterior nares are the predominant sites of colo-
nization in adults; carriage here has been associated with
the development of bacteremia [8]. Patients with SAB can
develop a broad array of complications which may be dif-
ﬁcult to recognize and often lead to disability or death. Com-
plications of SAB are common; frequencies range from 11–
53% [9, 10] and can occur in almost any body site. However,
certain complications are especially important because they
are diﬃcult to diagnose and are often associated with
poor outcome. Risk factors associated with development of2 Case Reports in Infectious Diseases
complications due to SAB vary depending on the route of
acquisition, site of infection, presence or absence of foreign
material, pathogen characteristics, and host predisposition.
Patients with community-acquired SAB have an increased
risk for metastatic complications [7, 11–15].
Fordecades,infectiveendocarditis(IE)causedbyStaphy-
lococcus aureus has been viewed primarily as a community-
acquired disease especially associated with injection drug use
(IDU) [15–21]. However, this syndrome has continued to be
a frequent clinical problem even in communities where IDU
is relatively uncommon. Its epidemiologic characteristics
seem to remain stable despite the advent/increase in the
frequency of multidrug-resistant organisms in both the
health-care and community environments as revealed by
an earlier study [11]. A comparison of nosocomial and
community-acquiredSABrevealsseveralfundamentaldiﬀer-
ences. Community-acquired SAB frequently develops in the
absence of a primary focus of infection and is more likely to
result in endocarditis and secondary metastatic foci of clini-
cal infection. In contrast, nosocomial SAB tends to be diag-
nosed earlier, a primary site of portal of entry is usually iden-
tiﬁedandendocarditisislessfrequentasaresecondaryfociof
infection. Irrespective of the epidemiological origin of SAB,
the mortality remains high particularly when nosocomially
acquired,wherethepresenceofsevereunderlyingdiseaseand
other comorbidities contribute to the high mortality.
The overall incidence of involvement of the tricuspid
valve in patients with infective endocarditis is in the range of
5% to 10%, with up to 80% of tricuspid valve endocarditis
occurring in drug addicts [11]. Right-sided endocarditis is a
clinical rarity in nondrug addicts without previous heart dis-
ease, and its diagnosis sometimes presents a signiﬁcant clini-
calchallenge[22].Right-sidedIEoccursmuchlessfrequently
in nonaddicted patients as a complication of permanent in-
travenous catheter placement, untreated skin or genital in-
fections[23–25],orunderlyingcongenitalheartdisease[26].
In these patients, endocarditis arising from S. aureus prima-
rily involves the left side of the heart and is associated with
mortality rates ranging from 25% to 40% [27]. Cure rates for
right-sided S. aureus endocarditis in IDUs are high (>85%)
and may be achieved with relatively short courses of treat-
ment [27]. A case of community-acquired S. aureus tricus-
pid valve endocarditis with metastatic abscesses in the lungs
and subcutaneous tissues in a patient with no obvious pre-
disposing conditions is presented here.
2. Case Presentation
A 49-year-old male, with no previous medical history pre-
sented to our emergency room (ER) with generalized body
pain that started 7 days prior to the visit. This was followed,
two days later, by a high-grade fever associated with chills
and rigors. During the week prior to his presentation to the
ER, he noticed some swellings over the right upper chest
and left calf that made it diﬃcult for him to walk. The pain
and fever improved with nonsteroidal anti-inﬂammatory
drugs(NSAIDs)whiletheswellingcontinued.Laterhisurine
became dark colored and he also noticed that his eyes had
turned yellow. Review of other systems was negative for any
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Figure 1: CT scan of the chest showing multiple abscess cavities.
major complaint. He was not on any long-term medications
and has denied any illicit intravenous drug use (IDU) or any
surgical or dental procedures.
Physical examination at the ER revealed a middle-aged
man who did not appear in any form of distress, febrile
(39◦C), not pale, but icteric. His other vital signs were nor-
mal.Warm,tender,andﬂuctuantswellingswerenoticedover
the right wrist, both calves, and below the right clavicle. All
otheraspectsofthephysicalexaminationwerenormal.There
werenoperipheralstigmataofIE,venipuncturemarks,heart
murmurs, or lymphadenopathy.
Investigations including aspirates from the abscesses for
culture and sensitivity were taken for culture and sensitivity.
Initial laboratory results revealed the following: total WBC-
18.5×109/L (with a left shift), platelet count-48,400,
hemoglobin level-13.4g/dL, BUN-25.1, serum creatinine-
237μmol/L, ALT-111, AST-118, alkaline phosphatase-271,
gamma GT-133, LDH-316, albumin-17, and total bilirubin-
129, (mainly direct-109), with normal serum electrolytes.
Imaging of the limbs, chest, abdomen, and pelvis revealed
multiple abscess collections in the calves, lungs, (Figures 1
and 2), and the right gluteal region. He also had right basal
atelectasis and right minimal pleural eﬀusion. He was empir-
icallystartedonbroadspectrumcoverageforthepreliminary
Gram-positive cocci (GPC) in clusters that were growing
from the peripheral blood and aspirates from the abscesses.
Theempiricantibioticsincludedvancomycinandcloxacillin,
bothgivenintravenously(IV).Thevancomycinwaslaterdis-
continued (and cloxacillin continued) when the ﬁnal culture
and sensitivity results from the peripheral blood and mul-
tiple abscesses yielded heavy growth of methicillin-sensitive
Staphylococcus aureus (MSSA). Gentamicin was added to the
cloxacillin for the ﬁrst fourteen days. He was also started on
anticoagulant therapy for the suspicion of PE; however, this
was stopped after the spiral CT was returned negative for PE.
Other laboratory tests revealed: C-reactive protein-
297mg/dL, erythrocyte sedimentation rate (ESR) of 75mm
intheﬁrsthour,andD-dimerlevelof1100.Serologictestsfor
HIV1 and HIV 2, HBsAg, and anti-HCV were all negative.Case Reports in Infectious Diseases 3
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Figure2:ChestX-rayofthechestshowingmultipleabscesscavities.
Spiral computed tomography (CT) scan of the chest was
not suggestive of pulmonary embolism (PE) and endoscopic
retrograde cholangiopancreatography (ERCP) was also neg-
ative. Transthoracic echocardiography (TTE) and transeso-
phageal echocardiography (TEE) revealed a large mass at-
tached to both septal and anterior tricuspid valve leaﬂets,
the biggest being 21mm in diameter; however, there was no
tricuspid regurgitation.
The patient’s management was later transferred under
theinfectiousdiseases(ID)servicefromthegastroenterology
unit under whom he was earlier admitted due to the elevated
liver enzymes and jaundice. During his hospital stay, he had
recurrentboutsofhighfeverswithchillsandrigors,tachycar-
dia, shortness of breath, diaphoresis, and feeling of impend-
ing doom with panic attacks and hypoxemia that necessi-
tated repeated chest imaging with no evidence of PE. The
abscesses were incised and drained, and the wounds man-
aged by wound care specialists with complete healing. Due
to the initial presentation, the patient was referred to various
specialties, including psychiatrists at diﬀerent times during
the course of his hospital stay.
As his condition improved, the fever subsided, the jaun-
dice cleared and the abscesses healed. Repeat blood culture
became negative within 24 hours. Complete blood count
(CBC) liver enzymes and bilirubin levels renal function and
coagulation proﬁle all normalized before his discharge.
The patient made remarkable improvement without any
new or recurrent problems and was discharged home after 6
weeks of intravenous cloxacillin therapy and given appoint-
ment to be seen in the ID clinic after 4 weeks.
3. Discussion
Isolated native TVE secondary to SAB without any docu-
mented risk factors has continued to develop, eluding diag-
nosis and often discovered late or only at autopsy [9, 10, 21].
Infection of the right heart valves appears in 5%–10% of all
cases and is almost always associated with intravenous drug
abuse, with more than 80% of tricuspid valve endocarditis
casesoccurringindrugaddicts[27].Communityacquisition
was associated with a rapidly progressive course and often
complicated with respiratory insuﬃciency, mimicking heart
failureorpulmonaryembolism[28].Tricuspidvalveinvolve-
ment in a patient with no predisposing conditions and a
structurally normal heart, as occurred in our patient, is a
clinicalrarityinwhichthediagnosiscanbequitechallenging.
Recurrentchestsymptoms(e.g.,shortnessofbreath,feel-
ing of choking with hypoxemia), febrile episodes, and feel-
ing of impending doom following wound dressing have re-
curred repeatedly in our patient. The constellation of these
chest symptoms in this group of patients is termed as
“the tricuspid syndrome” by some authors, and became
less prominent as the wounds healed. This was initially
thought to be due to pulmonary embolism or a form of psy-
chiatric presentation. However, spiral CT of the chest and
empiric therapy for pulmonary embolism and antipsychotic
medications were to no avail. Association of these features
with wound manipulation was later considered to be due to
what some authors called “the tricuspid syndrome,” and it
got less prominent as the wounds healed. This entity usually
has a good prognosis with good response to medical therapy,
and presents certain common clinical features (persistent
fever, pulmonary lesions, anemia, and microscopic hematu-
ria) that can lead the clinician to suspect the diagnosis. Some
of these manifestations are thought to be due to an immuno-
logical mechanism [29].
Our patient presented with metastatic abscesses in the
lungs that led to repeated episodes of shortness of breath
withhypoxemiaandwasinitiallythoughttohavepulmonary
embolism. This form of presentation was found to be signif-
icantly more common with community-acquired compared
with hospital-acquired SAB (43 versus 21 percent) [1]. Com-
munity-acquired SAB complicated by TV IE usually has
a better outcome than hospital-acquired infection though
Nolan and Beaty [15] reported that up to 60% (63/105) of
their patients had a mortality rate of 21% [30]. In a recent
study by Hill et al, 6% of their patients with SAB had IE
andtheyconcludedthatindependentpredictorsofIEamong
patients with SAB included unknown origin of bactere-
mia, presence of a valvular prosthesis, persistent fever, and
persistent bacteremia. The strongest predictor of compli-
cated SAB was found to be a positive follow-up blood culture
result at 48–72 hours [13]. Four risk factors (community
acquisition, skin examination ﬁndings suggesting acute sys-
temic infection, persistent fever at 72 hours, and positive fol-
low-up blood culture results at 48 to 96 hours) have been
found to accurately identify complicated SAB. Our patient
had three of these risk factors.
With the recurrent chest symptoms and a positive blood
culture for Staphylococcus aureus bacteremia, a TEE was
performedaccordingtocurrentguidelines[31,32],andmul-
tiple vegetations were identiﬁed (Figure 3). All patients with
SAB should undergo a TEE irrespective of whether a risk fac-
torforIEhasbeenidentiﬁedornottoavoidtheuncertainties
that plagued previous studies [30].
The index case was treated with intravenous cloxacillin,
and also additionally received gentamicin for the ﬁrst two
w e e k sf o ri t ss y n e r gi s t i ce ﬀect; then cloxacillin was continued4 Case Reports in Infectious Diseases
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Figure 3: Algorithm for the use of transthoracic (TTE) and transesophageal echocardiography (TEE) in suspected IE. Note: TTE “positive”
indicates ﬁnding typical of IE (e.g., fresh vegetation or abscess formation).
for the remaining 4 weeks. The beneﬁt of gentamicin in na-
tive valve endocarditis lies in earlier defervescence of fever
andthesterilizationofbloodcultures;thereisnoprovensur-
vival advantage. Our patient remained on admission for six
weeks for intravenous antibiotic therapy with favorable out-
come. Before discharge, his temperature, blood counts, coag-
ulation proﬁle, renal, and hepatic functions had normalized
without additional interventions. Several studies have re-
ported the beneﬁts of combined β-lactam/aminoglycoside
short-course (2 weeks) therapy in patients with complicated
Staphylococcus aureus endocarditis (with evidence of renal
failure and extrapulmonary metastatic foci) [33–37]. This
study conﬁrms this. By contrast, glycopeptide (teicoplanin or
vancomycin) plus gentamicin-based short-course regimens
appeared to be less eﬀective for right-sided S. aureus IE
caused by oxacillin-susceptible S. aureus (OSSA) [30]. Gly-
copeptides are intrinsically less active against staphylococci
than are antistaphylococcal β-lactams [28, 29].
Prognosis of tricuspid valve endocarditis is favorable,
and most cases respond to antibiotic therapy [38]. However,
surgicaltreatmentshouldbeconsideredforthosewithsevere
congestive heart failure, persistent sepsis, development of ab-
scesses, and mycotic endocarditis. Other major indications
for surgery will include the presence of large tricuspid valve
vegetations (>1cm) with persistent fever, tricuspid valve
insuﬃciency or pulmonary embolization [39, 40]. Our pa-
tientdidwellonmedicaltherapyalone,althoughsurgerywas
considered an option at the outset.
We suggest that right-sided endocarditis must be con-
sidered in any patient with the “tricuspid syndrome,” with
recurrent pulmonary events, anemia, and microscopic he-
maturia. Careful evaluation of prior medical records and
clinical course can be very helpful. Echocardiography and
serial blood cultures provide the key to diagnosis.
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